Related Experiment Video
Updated: May 31, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Single-Fraction Stereotactic Body Radiotherapy for Early-Stage Lung Adenocarcinoma Within Atelectasis.
Joseph Daniels1, Benjamin Mou1
1Radiation Oncology, BC Cancer Kelowna, Kelowna, CAN.
Cureus
|May 29, 2026
Summary
Single-fraction stereotactic body radiotherapy (SBRT) is feasible for early-stage non-small cell lung cancer (NSCLC) within atelectasis. While achieving short-term metabolic response, long-term control and management strategies require further investigation.
Area of Science:
- Oncology
- Radiation Oncology
- Pulmonary Medicine
Background:
- Stereotactic body radiotherapy (SBRT) is a non-invasive treatment for early-stage non-small cell lung cancer (NSCLC).
- Tumors within atelectasis pose challenges for SBRT due to anatomical distortion and visualization difficulties.
- Medically inoperable patients with early-stage NSCLC and severe COPD are candidates for SBRT.
